Contrariwise, others reported a diminished Aβ accumulation on AD brains after IGF1 treatment, while IGF1R inhibition aggravated both behavioral and pathological AD symptoms in mice [60,61]. This evidence concerns the gene IGF1 and Alzheimer disease.